Praxis Precision Medicines, Inc.

PRAX·NasdaqGS·Healthcare
Compare
284.79+4.28 (+1.53%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close280.51
Open286.87
Day range274.27287.55
52-week range154.45392.70
Off day high−0.96%
Off 52-week high−27.48%
Volume304.60K
Avg. volume (3M)458.53K
Market cap7.95B
EPS (TTM)-12.95
Forward P/E-29.97
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.84
Shares outstanding27.92M
Short interest14.08% of float
Earnings dateNov 9, 2026
Analyst target650.00
Profit margin0.00%

Against its peers

Compare in full ›
PRAX SANION.ST AXSM ACAD XENE PTCT
Market cap 7.95B 1.53B 7.21B 3.70B 3.80B 5.76B
P/E (TTM) — 8.6 — 9.6 — —
Forward P/E -30.0 — 34.0 23.3 -8.3 28.4
Price/book 5.9 2.8 68.3 3.0 3.1 -30.1
Dividend yield — — — — — —
1-year change +70.38% −36.20% −1.73% −7.88% +2.32% −5.09%
Today +1.53% +3.45% −1.87% +4.38% +2.51% +1.25%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Praxis Precision Medicines's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Saniona AB (publ)SANION.ST · Biotechnology 1.53B 11.11 +3.45%
Axsome Therapeutics, Inc.AXSM · Biotechnology 7.21B 137.00 −1.87%
Acadia Pharmaceuticals Inc.ACAD · Biotechnology 3.70B 21.47 +4.38%
Xenon Pharmaceuticals Inc.XENE · Biotechnology 3.80B 39.19 +2.51%
PTC Therapeutics, Inc.PTCT · Biotechnology 5.76B 68.97 +1.25%
Rapport Therapeutics, Inc.RAPP · Biotechnology 1.50B 25.93 +1.93%
AtaiBeckley Inc.ATAI · Biotechnology 2.73B 7.35 0.00%
BioArctic AB (publ)B9A.F · Biotechnology 2.45B 27.58 −0.29%

Also based in Boston, Massachusetts, then elsewhere in Massachusetts.

Company Mkt cap Price Today
Vertex Pharmaceuticals IncorporatedVRTX · Boston, MA 139.16B 549.04 +3.44%
American Tower CorporationAMT · Boston, MA 90.37B 194.86 +4.04%
Wayfair Inc.W · Boston, MA 16.92B 123.56 +11.00%
State Street CorporationSTT · Boston, MA 47.18B 173.41 +2.18%
PTC Inc.PTC · Boston, MA 21.20B 195.18 +0.58%
Toast, Inc.TOST · Boston, MAOdds 20.44B 35.37 +5.49%
Dynatrace, Inc.DT · Boston, MA 13.42B 46.78 −0.53%
BXP, Inc.BXP · Boston, MA 11.93B 65.96 +5.32%

The stocks whose daily moves over the past year went most closely with Praxis Precision Medicines's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Kymera Therapeutics, Inc.KYMR · Correlation 0.41 11.63B 136.25 +7.21%
Rapport Therapeutics, Inc.RAPP · Correlation 0.40 1.50B 25.93 +1.93%
Scholar Rock Holding CorporationSRRK · Correlation 0.38 5.61B 46.09 +4.80%
Rhythm Pharmaceuticals, Inc.RYTM · Correlation 0.36 7.67B 110.68 +28.04%
ABIVAX Société AnonymeABVX · Correlation 0.31 7.83B 89.49 +0.88%

What visitors to Praxis Precision Medicines's page also look at.

Company Mkt cap Price Today
Olema Pharmaceuticals, Inc.OLMA 659.73M 7.54 +2.59%
Kymera Therapeutics, Inc.KYMR 11.63B 136.25 +7.21%
Edgewise Therapeutics, Inc.EWTX 4.08B 37.53 −0.40%
Vaxcyte, Inc.PCVX 10.34B 65.68 +8.01%
Scholar Rock Holding CorporatioSRRK 5.61B 46.09 +4.80%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All PRAX news ›
Defense World··2 outletsPositive

Praxis Precision Medicines (NASDAQ:PRAX) and Relay Therapeutics (NASDAQ:RLAY) Financial Review

Posted by Defense World Staff on Oct 27th, 2026 Praxis Precision Medicines (NASDAQ:PRAX – Get Free Report) and Relay Therapeutics (NASDAQ:RLAY – Get Free Report) are both mid-cap healthcare companies, but which is the better stock? We will…

PRAXVRTXRLAYJPM
More from 1 other outlet
Markets Daily··2 outlets

Praxis Precision Medicines (NASDAQ:PRAX) Stock Rated “Overweight” in New Coverage at JPMorgan Chase & Co.

Posted by Tristan Rich on Oct 19th, 2026 JPMorgan Chase & Co. initiated coverage on shares of Praxis Precision Medicines (NASDAQ:PRAX – Free Report) in a research report released on Friday morning, Marketbeat reports. The brokerage issued…

PRMEPRAXTRAXBCS
More from 1 other outlet

From the 4Search news index, newest first.

In the news

9mentions in 30 days
9with it in the headline
Positivesentiment

Mentioned with

JPMorgan Chase & CO5JPMorgan Chase & Co.5Praxis Precision Medicines, Inc5Arbutus Biopharma3Avalo Therapeutics3Btig Research3Weiss Ratings3Bank of America2

People in the coverage

Danessa Lincoln9Benzinga8Michael Walen8Sarita Garza8HC Wainwright7Kim Johansen7

Themes

Healthcare7EPS6Analyst Recommendations3Comparison3Consensus3Dividends3Earnings3Institutional Ownership3

Most coverage from

  1. themarketsdaily.com4
  2. defenseworld.net2
  3. marketscreener.com2
  4. tradingview.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance